% Expired Patents = 33.3

CIPO Patents = 6

EPO Patents = 1

Forward Citations = 203

Loading Chart...

7 inventors (with patents filed for the assignee):

Nathan Bryson (6 out of 14 patents)

Anthony John Giovinazzo (6 out of 15 patents)

Scott David Barnhart (4 out of 27 patents)

4. Michael Clinton Koons (4 out of 8 patents)

5. David Bruce Hedden (2 out of 12 patents)

6. Marc L De Somer (2 out of 7 patents)

7. Nathan John Bryson (0 patent)

8. Marc L De Somer (0 patent)

9. Marc L De Somer (0 patent)

6 patents: Sort by Forward Citations

1. 9427412 - Sublingual films (2016-08-30),

2. 9326981 - Sublingual apomorphine (2016-05-03),

3. 9283219 - Sublingual films (2016-03-15),

4. 9044475 - Sublingual apomorphine (2015-06-02),

5. 8846074 - Sublingual films (2014-09-30),

6. 8414922 - Sublingual films (2013-04-09),

Cynapsus Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative therapies for Parkinson's disease. Their lead product candidate, APL-130277, is a sublingual film of apomorphine for the treatment of off episodes in Parkinson's disease patients. The company is committed to improving the lives of individuals living with neurological disorders through advanced drug development.

Profile summary based on public USPTO records.